Study reveals how a viral toxin may contribute to severe COVID-19 infection
A new study in the journal Nature Communications reveals how a viral toxin produced by the SARS-CoV-2 virus may contribute to severe COVID-19 infections.
Stay updated with breaking news from Bedema. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study in the journal Nature Communications reveals how a viral toxin produced by the SARS-CoV-2 virus may contribute to severe COVID-19 infections.
Highly eminent, Dr. Mohammad Chikh Atieh, Consultant Internal Medicine at the Al Mahmoud Medical Center, adopts the geko device for the prevention of venous thromboembolism (VTE) and the reduction
Allergic contact dermatitis from ophthalmic medications may not be suspected or may be misinterpreted as other skin or eye conditions.
A Lancet editorial calls for 'tempering hype and hope' over lecanemab for Alzheimer's disease, which provided modest benefit with safety concerns in the CLARITY AD trial.
Final results from a phase 3 trial with the investigational DCVax-L vaccine show that overall survival was increased both in patients with newly diagnosed glioblastoma as well as recurrent disease.